AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Comparing CARTY Cells and Bi-specific Antibodies in Multiple Myeloma Treatment
Speakers discuss the effectiveness and considerations of CARTY cells versus bi-specific antibodies for multiple myeloma patients, highlighting the evolving landscape of therapies and emphasizing the importance of individualized patient choices.